Myeloid Cell Reprogramming in Thyroid Carcinoma

CompletedOBSERVATIONAL
Enrollment

41

Participants

Timeline

Start Date

March 6, 2018

Primary Completion Date

November 26, 2019

Study Completion Date

January 5, 2021

Conditions
Thyroid Cancer
Trial Locations (1)

6525GA

Radboudumc, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT03397238 - Myeloid Cell Reprogramming in Thyroid Carcinoma | Biotech Hunter | Biotech Hunter